NCT00003611View on ClinicalTrials.gov

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

February 28, 2003

Study Completion Date

June 30, 2003

Conditions
Non-melanomatous Skin Cancer
Interventions
DRUG

acitretin

OTHER

placebo

Trial Locations (11)

32224

Mayo Clinic, Jacksonville

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Health Plaza, Saint Cloud

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

57709

Rapid City Regional Hospital, Rapid City

58501

Medcenter One Health System, Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

67214-3882

CCOP - Wichita, Wichita

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00003611 - Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation | Biotech Hunter | Biotech Hunter